Noël Bouck

16.9k citations

93 papers · 13.8k indexed · 6 hit papers · h-index 53

Impact in

Cancer Research top 0.1%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research

Papers in

Cancer Research 43
- Protease and Inhibitor Mechanisms 15
- Cancer, Hypoxia, and Metabolism 14
- Carcinogens and Genotoxicity Assessment 10
Immunology and Allergy 7
- Cell Adhesion Molecules Research 7

Co-authors: Olga V. Volpert Peter J. Polverini Susan E. Crawford Veronica Stellmach Michael A. Tainsky David W. Dawson Farzan Rastinejad Roy L. Silverstein
Journals: Proceedings of the National Academy of Sciences (8 papers)Journal of Virology (5 papers)Nature Medicine (4 papers)Molecular and Cellular Biology (4 papers)Science (3 papers)
Partner nations: United States Germany France

In The Last Decade

Noël Bouck

93 papers receiving 13.3k citations

Hit Papers

6 papers align trajectories log scale

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 2000 · 831 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2000 Nature Medicine
1999 Science
1998 Cell
1997 The Journal of Cell Biology
1994 Science
1990 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Noël Bouck

Since Specialization

Citations

This map shows the geographic impact of Noël Bouck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noël Bouck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noël Bouck more than expected).

Fields of papers citing papers by Noël Bouck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noël Bouck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noël Bouck. The network helps show where Noël Bouck may publish in the future.

Co-authors

The 25 scholars most cited alongside Noël Bouck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noël Bouck Line = papers co-authored together Noël Bouck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Proliferative Diabetic Retinopathy is Associated with a Low Level of the Natural Ocular Anti-angiogenic Agent Pigment Epithelium-derived Factor (PEDF) in Aqueous Humor. A Pilot Study Hormone and Metabolic Research ·Edward Boyle, Günter Lang, Barbara Feldmann, W W Cleland, Silke Rosinger, Olga V. Volpert, Noël Bouck	2003	28
2	PEDF: anti-angiogenic guardian of ocular function Trends in Molecular Medicine ·Noël Bouck	2002	189
3	Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor Nature Medicine ·Olga V. Volpert, Tetiana Zaichuk, Wei Zhou, Frank Reiher, Thomas A. Ferguson, Patrick M. Stuart, M. Asif Amin, Noël Bouck	2002	337
4	Thrombospondin‐1, vascular endothelial growth factor and fibroblast growth factor‐2 are key functional regulators of angiogenesis in the prostate The Prostate ·Jennifer A. Doll, Frank Reiher, Susan E. Crawford, Michael R. Pins, Steven C. Campbell, Noël Bouck	2001	115
5	THE ROLE OF HYPOXIA AND p53 IN THE REGULATION OF ANGIOGENESIS IN BLADDER CANCER The Journal of Urology ·N. А. Andreev, Marija Ivanović, Haojie Huang, Norm D. Smith, Noël Bouck, Steven C. Campbell	2001	8
6	Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nature Medicine ·Benilde Jiménez, Olga V. Volpert, Susan E. Crawford, Maria Febbraio, Roy L. Silverstein, Noël Bouck Hit paper breakdown →	2000	831
7	A Pilot Trial of Suramin in Metastatic Breast Cancer to Assess Antiangiogenic Activity in Individual Patients Oncology ·William J. Gradishar, Gerald A. Soff, Jiangou Liu, Angela Cisneros, Đurđica Košuljandić, Alfred Rademaker, Al B. Benson, Noël Bouck	2000	19
8	Three Distinct d-Amino Acid Substitutions Confer Potent Antiangiogenic Activity on an Inactive Peptide Derived from a Thrombospondin-1 Type 1 Repeat Molecular Pharmacology ·David W. Dawson, Olga V. Volpert, S. Frieda A. Pearce, Andrew J. Schneider, Roy L. Silverstein, Jack Henkin, Noël Bouck	1999	116
9	The Anticancer Drug Edelfosine Is a Potent Inhibitor of Neovascularization In Vivo Cancer Investigation ·William R. Vogler, Jianguo Liu, Olga V. Volpert, Edwin W. Ades, Noël Bouck	1998	13
10	Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. PubMed ·Stephanie Hsu, Olga V. Volpert, Peter A. Steck, Tom Mikkelsen, Peter J. Polverini, Sambasiva Rao, Pauline M. Chou, Noël Bouck	1996	119
11	P53 and angiogenesis Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Noël Bouck	1996	64
12	How Tumors Become Angiogenic Advances in cancer research ·Noël Bouck, Veronica Stellmach, Stephanie Hsu	1996	404
13	Inhibition of Angiogenesis by Thrombospondin-2 Biochemical and Biophysical Research Communications ·Olga V. Volpert, Sara S. Tolsma, Sylvie Pellerin, Jean‐Jacques Feige, 富永英義, D F Mosher, Noël Bouck	1995	162
14	The distal region of the long arm of human chromosome 1 carries tumor suppressor activity for a human fibrosarcoma line Cancer Genetics and Cytogenetics ·Karin Klein, Noël Bouck	1994	8
15	Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1 Science ·V. Bhagat, Olga V. Volpert, Michael A. Tainsky, Noël Bouck Hit paper breakdown →	1994	1150
16	Transformation of NIH/3T3 to Anchorage Independence by H-Ras Is Accompanied by Loss of Suppressor Activity Experimental Cell Research ·Sara S. Tolsma, Justin D. Cohen, Lorna S. Ehrlich, Noël Bouck	1993	2
17	Assay and purification of naturally occurring inhibitor of angiogenesis Methods in enzymology on CD-ROM/Methods in enzymology ·Peter J. Polverini, Noël Bouck, Farzan Rastinejad	1991	71
18	Loss of cancer suppressors, a driving force in carcinogenesis Chemical Research in Toxicology ·Noël Bouck, Khairul Shafee Khalid	1989	9
19	Phagocyte‐Mediated Carcinogenesis: DNA from Phagocyte‐Transformed C3H 10T1/2 Cells Can Transform NIH/3T3 Cells ^a Annals of the New York Academy of Sciences ·Sigmund A. Weitzman, Xiawei Feng, Patrick W. Turk, Craig W. Stevens, Sara S. Tolsma, Noël Bouck	1988	11
20	Induction of a Step in Carcinogenesis That Is Normally Associated with Mutagenesis by Nonmutagenic Concentrations of 5-Azacytidine Molecular and Cellular Biology ·Noël Bouck, E. Kun, Julie Ostrowsky	1984	24

About Noël Bouck

Noël Bouck is a scholar working on Cancer Research, Immunology and Allergy, Molecular Biology, Ophthalmology and Biotechnology, having authored 93 papers that have together received 13.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (43 papers), Protease and Inhibitor Mechanisms (15 papers), Cancer, Hypoxia, and Metabolism (14 papers), Carcinogens and Genotoxicity Assessment (10 papers), DNA Repair Mechanisms (9 papers), Corneal Surgery and Treatments (8 papers), Cancer-related Molecular Pathways (7 papers) and Cell Adhesion Molecules Research (7 papers). The work is most often cited by research in Cancer Research (4.4k citations), Immunology and Allergy (1.4k citations), Ophthalmology (1.5k citations), Molecular Biology (9.5k citations) and Oncology (2.9k citations). Noël Bouck has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Olga V. Volpert, Peter J. Polverini, Susan E. Crawford, Veronica Stellmach, Michael A. Tainsky, David W. Dawson, Farzan Rastinejad, Roy L. Silverstein, William A. Frazier and Jack Lawler. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Virology, Nature Medicine, Molecular and Cellular Biology and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact